Trade now with Barclays Stockbrokers
02-Jul-25 |
Sell |
Philip Bowcock |
76.21p | 181,000 |
£137,940.10 |
16-Jun-25 |
Sell |
Daniel Barton |
77.65p | 90,418 |
£70,209.58 |
16-Jun-25 |
Exercise of option |
Daniel Barton |
0.000p | 191,694 |
£0.00 |
02-Jul-25 |
Sell |
Philip Bowcock |
76.21p | 181,000 |
£137,940.10 |
16-Jun-25 |
Sell |
Daniel Barton |
77.65p | 90,418 |
£70,209.58 |
16-Jun-25 |
Exercise of option |
Daniel Barton |
0.000p | 191,694 |
£0.00 |
Mark Radcliffe |
155,733,657 |
£113,374,102 |
Philip Bowcock |
893,718 |
£650,627 |
Daniel Barton |
273,062 |
£198,789 |
Damian Sanders |
25,933 |
£18,879 |
Dianne Walker |
22,154 |
£16,128 |
Neil Radcliffe |
35,592,130 |
£25,911,071 |
|
Interim |
Final |
Ex-Div |
17-Jul-25 |
06-Feb-25 |
Paid |
15-Aug-25 |
07-Mar-25 |
Amount |
0.70p |
1.09p |
16:35 |
14,668 @ 72.80p |
16:35 |
181 @ 72.80p |
16:35 |
576 @ 72.80p |
16:35 |
511 @ 72.80p |
16:35 |
656 @ 72.80p |
Chair |
Philip Bowcock |
CEO |
Mark Radcliffe |
CFO |
Daniel Barton |
Top of Page
You are here:
research